approval · primary record
PERTUZUMAB-DPZB
FDA · BLA · 2025-11-13
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-11-13 |
| Brand | POHERDY |
| Sponsor | SHANGHAI HENLIUS BIOTECH |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:02.139Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:PERTUZUMAB-DPZB:2025-11-13
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.